Menu

Dr. David H. Harpole, Jr. currently holds the position of Associate Professor of Surgery and Assistant Professor of Pathology at Duke University Medical Center in Durham, North Carolina.

Research interests for Dr. Harpole focus on general thoracic surgery, advanced airway and thoracoscopic surgery, benign and malignant disease of the lung, esophagus and mediastinum; esophageal cancer, oncology, and hyperhidrosis palmaris.

Other research interests include non-small cell lung cancer, and clinical research on the development of esophageal cancer treatment protocol as well as the creation of databases, the development of risk associated models of morbidity in cancer patients that undergo thoracic surgery procedures, as well as the cost and satisfaction evaluation of thoracoscopy and open throacotomy in cancer patients. Dr. Harpole has authored or co-authored a number of scholarly publications to share his knowledge with others in the medical field.

Main Specialty: Thoracic Surgeon

Other Interests & Specialties: Mesothelioma and thymoma clinical trials, pneumonectomy, genomics of lung cancer and mesothelioma, new drug development, melanoma, thoracoscopy, esophagus cancer, squamous cell carcinoma and minimally invasive thoracic surgery.

Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Surgery Certification in Thoracic and Cardiac Surgery, ACS Fellow, Maxwell’s Who’s Who of North America, Who’s Who in Medical Sciences Education, Cancer Doctors for Women, National Science Foundation Research Scholar, International Health Professional of the Year, CMS Stage 1 EHR

Education & Experience:

  • Medical Degree from University of Virginia School of Medicine
  • Residency for General Surgery at Duke University Medical Center
  • Fellowship for Thoracic Surgery at Duke University Medical Center
  • Fellowship for Thoracic Oncology at Dana Farber Cancer Institute, Harvard Medical School

Publications: 
Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung CancerThe Annals of Surgery. December 2018;268(6):1105-1112. doi: 10.1097/SLA.0000000000002287

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationJournal of Thoracic Oncology. November 2018;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036

Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural MesotheliomaClinical Lung Cancer. September 2016;419-426. doi: 10.1016/j.cllc.2016.03.002

Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results databaseThe Journal of Surgical Research. June 2015;196(1):23-32. doi: 10.1016/j.jss.2015.01.043

Photo of Dr. David H. Harpole, Jr.

Get Help Contacting Dr. David H. Harpole, Jr.


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe